Cargando…
Imatinib-induced Extensive Hyperpigmentation in a Case of Chronic Myeloid Leukemia
Imatinib, a tyrosine kinase inhibitor, is well known to cause hypopigmentation because of its inhibitory effect on melanocytes. Herewith we report a case of chronic myeloid leukemia who developed extensive hyperpigmentation following imatinib therapy.
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4601460/ https://www.ncbi.nlm.nih.gov/pubmed/26538739 http://dx.doi.org/10.4103/0019-5154.164447 |